India  

New variant may force drug companies to tweak Covid vaccination plans

IndiaTimes Monday, 29 November 2021
The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday that they had initiated work on developing new versions of their respective vaccines adapted to the mutant strain. Pfizer and Moderna too said they were racing to tweak their vaccines.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Novavax COVID-19 vaccine Novavax COVID-19 vaccine Vaccine candidate against COVID-19

India approves 2 Covid vaccines, 1 covid pill | Corbevax, Covovax & Molnupiravir |  Oneindia News [Video]

India approves 2 Covid vaccines, 1 covid pill | Corbevax, Covovax & Molnupiravir | Oneindia News

The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the Covid-19 pandemic. #Omicron #Covid19 #Covovax #Corbevax #Molnupiravir

Credit: Oneindia    Duration: 01:42Published
European Union Approves Novavax Coronavirus Vaccine [Video]

European Union Approves Novavax Coronavirus Vaccine

European Union Approves , Novavax Coronavirus Vaccine. ABC News reports the European Union has authorized the use of the Novavax COVID-19 vaccine. Manufactured in the United States, Novavax's two-dose vaccine will be the fifth coronavirus vaccine approved by the European Union. Manufactured in the United States, Novavax's two-dose vaccine will be the fifth coronavirus vaccine approved by the European Union. According to ABC News, the European Union has ordered around 100 million doses of the Novavax vaccine. Research conducted by the European Medicines Agency shows "the data on the vaccine were robust and met the EU criteria for efficacy, safety, and quality.” . The Novavax vaccine is protein-based, a technique long used in vaccine production. . In a study of 30,000 citizens of the United States and Mexico, the vaccine was proven safe and 90% effective against earlier variants of the coronavirus. In a study of 30,000 citizens of the United States and Mexico, the vaccine was proven safe and 90% effective against earlier variants of the coronavirus. The Novavax vaccine only requires refrigeration to remain effective. Experts say this trait could minimize the impact of global vaccine inequity. Novavax CEO Stanley C. Erck said the decision would “deliver the vaccine to the E.U. during a critical time when we believe having choice among vaccines will lead to increased immunization.”. Novavax CEO Stanley C. Erck said the decision would “deliver the vaccine to the E.U. during a critical time when we believe having choice among vaccines will lead to increased immunization.”

Credit: Wibbitz Top Stories    Duration: 01:31Published
Covovax should be India's booster shot, says top govt scientist | Oneindia News [Video]

Covovax should be India's booster shot, says top govt scientist | Oneindia News

On a day that the WHO granted emergency use authorisation to the SII manufactured Covovax, top government scientist Anurag Agrawal said that it should be rolled out as a Covid booster shot. #Omicron #BoosterShot #Covovax

Credit: Oneindia    Duration: 02:01Published
Covovax approved by WHO, SII CEO Adar Poonawalla calls it milestone | Oneindia News [Video]

Covovax approved by WHO, SII CEO Adar Poonawalla calls it milestone | Oneindia News

The World Health Organisation (WHO) on Friday issued an emergency use listing for Covovax, Serum Institute of India's version of Novavax Inc's Covid-19 vaccine. Delhi University is set to adopt a common entrance test for undergraduate admissions from 2022, giving a relief to students from sky high cut off marks; Congress leader Priyanka Gandhi Vadra said she "wholeheartedly condemns" the statement of the Karnataka Congress MLA who stirred a massive outrage making 'indefensible' comments on rape. All this and more news at 9 PM. #DUentrance #Covovax #PriyankaGandhi

Credit: Oneindia    Duration: 03:20Published
India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News [Video]

India’s GDP grows by 8.4% in the second quarter of Financial Year 2021-22 | Oneindia News

India’s GDP grows by 8.4% in July-September; Adar Poonawalla said that children in India should be vaccinated with the Covovax coronavirus vaccine; A new study in the Lancet indicates that the Covishield vaccine against coronavirus remained effective during the Delta variant outbreak; CM Basavaraj Bommai said that the Karnataka government is not looking at any proposal for a statewide lockdown in the wake of the Omicron threat. #GDP #India #Omicron India's GDP grows by 8.4%, Financial Year 2021-22, India’s economic growth, Serum Institute CEO Adar Poonawalla, Covovvax, Vaccination children, Covishield, Lancet study, Delta variant outbreak, Omicron alert, Karnataka CM Basavaraj Bommai, Karnataka government.

Credit: Oneindia    Duration: 02:27Published

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Javid insists NHS staff are first in line for Covid tests [Video]

Javid insists NHS staff are first in line for Covid tests

Health secretary Sajid Javid insists NHS staff are being prioritised for Covid testing, despite the British Medical Association and Royal College of Nursing raising concerns over the availability of tests for frontline workers. Report by Chinnianl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:55Published
Dutch tourists flock to Belgium to escape New Year COVID lockdown at home [Video]

Dutch tourists flock to Belgium to escape New Year COVID lockdown at home

Thousands of Dutch visitors have been out and about in Antwerp shopping as well as eating and drinking in bars and cafés that are shut down in the Netherlands.

Credit: euronews (in English)    Duration: 01:13Published
'Welcome 2022!': Sydney sees in New Year with dazzling fireworks display [Video]

'Welcome 2022!': Sydney sees in New Year with dazzling fireworks display

The Australian city shrugged off a COVID surge with a spectacular Harbour Bridge display, while in New Zealand Auckland's celebration was a far more low-key affair.

Credit: euronews (in English)    Duration: 01:02Published
Covid-19 in France: 'Health' measures are more 'political or economical' in nature [Video]

Covid-19 in France: 'Health' measures are more 'political or economical' in nature

Credit: FRANCE 24 English    Duration: 03:38Published
Snow, ice close COVID test sites in Seattle-area [Video]

Snow, ice close COVID test sites in Seattle-area

Amid a COVID-19 surge, health officials closed coronavirus testing sites or reduced hours in the Seattle-area because of days of snow and freezing temperatures.

Credit: euronews (in English)    Duration: 01:00Published

Pfizer Pfizer American multinational pharmaceutical corporation

COVID-19 Pills May Conflict With Certain Medications, Study Finds [Video]

COVID-19 Pills May Conflict With Certain Medications, Study Finds

COVID-19 Pills May Conflict With , Certain Medications, Study Finds. NBC News reports experts are warning anti-viral pills created by Pfizer and Merck may not be safe for everyone. Recently cleared by the Food and Drug Administration to treat infections in patients 12 and older, anti-viral pills have been a cause for optimism in the fight against COVID-19. According to NBC News, experts have found that certain ingredients in the anti-viral pills may cause extreme reactions when paired with more widely-used medications. Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications. Oddly enough, many of the affected medications are widely prescribed to those with the highest risk of developing COVID-19 complications. These medications include antidepressants, immunosuppressants and even inhalers. These medications include antidepressants, immunosuppressants and even inhalers. Some of these potential interactions are not trivial, and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some of these potential interactions are not trivial, and some pairings have to be avoided altogether. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some are probably easily managed. But some we’re going to have to be very careful about. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Some are probably easily managed. But some we’re going to have to be very careful about. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. Amid concerns, experts remain excited by the potential of anti-viral pills. This could make a real difference in the pandemic by making an effective Covid treatment available to many people. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News. This could make a real difference in the pandemic by making an effective Covid treatment available to many people. , Peter Anderson, professor of pharmaceutical science, University of Colorado, via NBC News

Credit: Wibbitz Top Stories    Duration: 01:30Published
US health regulator authorizes Pfizer's Covid-19 pill as Omicron surges [Video]

US health regulator authorizes Pfizer's Covid-19 pill as Omicron surges

Credit: FRANCE 24 English    Duration: 01:50Published
Pfizer's Antiviral COVID-19 Pill Authorized by FDA [Video]

Pfizer's Antiviral COVID-19 Pill Authorized by FDA

Pfizer's Antiviral COVID-19 Pill , Authorized by FDA. NPR reports the Food and Drug Administration has officially authorized the first COVID-19 antiviral pill. The pill, Paxlovid, was created by pharmaceutical company Pfizer. Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization. . Experts say Pfizer's pill could keep those infected with COVID-19 from becoming ill enough to require hospitalization. . According to NPR, the pill is meant to be ingested twice a day for five days. Paxlovid will reportedly require a tandem dose of generic antiviral medicine ritonavir. Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic. , Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR. Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill — a major step forward in the fight against this global pandemic. , Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research, via NPR. Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%. Pfizer's studies suggest taking Paxlovid within three days of exhibiting symptoms could reduce the risk of death and hospitalization by 89%. NPR reports separate studies showed the pill only reduced 70% of hospitalizations. Experts say the effectiveness of Paxlovid shouldn't diminish when treating Omicron-related infections. The United States will reportedly purchase 10 million courses of Pfizer's new COVID-19 treatment. Pfizer says around 180,000 courses of treatment will be available by the end of the year

Credit: Wibbitz Top Stories    Duration: 01:30Published
Omicron positive despite 3 vaccine shots | Mumbai patient hospitalised | Oneindia News [Video]

Omicron positive despite 3 vaccine shots | Mumbai patient hospitalised | Oneindia News

A man has tested positive for the Omicron strain of the coronavirus despite having had 3 shots of the Pfizer vaccine, according to authorities in Mumbai. #Omicron #Mumbai #PfizerVaccine

Credit: Oneindia    Duration: 02:00Published
Pfizer says Covid-19 pill drastically reduces severe disease [Video]

Pfizer says Covid-19 pill drastically reduces severe disease

Credit: FRANCE 24 English    Duration: 01:27Published

Moderna COVID-19 vaccine Moderna COVID-19 vaccine RNA COVID-19 vaccine

Moderna Says Their Booster Shot Raises Level of Antibodies Against Omicron [Video]

Moderna Says Their Booster Shot Raises Level of Antibodies Against Omicron

Moderna Says Their Booster Shot, Raises Level of Antibodies, Against Omicron Variant. Moderna Says Their Booster Shot, Raises Level of Antibodies, Against Omicron Variant. CNN reports vaccine maker Moderna says research suggests a booster shot of its coronavirus vaccine increases antibody levels against the Omicron variant. CNN reports vaccine maker Moderna says research suggests a booster shot of its coronavirus vaccine increases antibody levels against the Omicron variant. Moderna's booster shot is administered in a 50 microgram dose. The company says one dose of its booster shot can increase antibody levels 37 fold. Moderna CEO Stéphane Bancel says these numbers are "reassuring.". The dramatic increase in COVID-19 cases from the Omicron variant is concerning to all. , Stéphane Bancel, CEO Moderna, via CNN. The dramatic increase in COVID-19 cases from the Omicron variant is concerning to all. , Stéphane Bancel, CEO Moderna, via CNN. ...the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost levels.., Stéphane Bancel, CEO Moderna, via CNN. ...the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost levels.., Stéphane Bancel, CEO Moderna, via CNN. Despite the good news, Moderna will reportedly continue in its work to create an Omicron-specific vaccine. Despite the good news, Moderna will reportedly continue in its work to create an Omicron-specific vaccine. Moderna will continue to rapidly advance an Omicron-specific booster candidate into clinical testing in case it becomes necessary in the future. , Stéphane Bancel, CEO Moderna, via CNN. Moderna will continue to rapidly advance an Omicron-specific booster candidate into clinical testing in case it becomes necessary in the future. , Stéphane Bancel, CEO Moderna, via CNN. Per the U.S. Centers for Disease Control and Prevention, 32% of fully-vaccinated Americans have received a booster dose of a COVID-19 vaccine. Per the U.S. Centers for Disease Control and Prevention, 32% of fully-vaccinated Americans have received a booster dose of a COVID-19 vaccine

Credit: Wibbitz Top Stories    Duration: 01:31Published
Moderna 'confident' jab will protect against Omicron [Video]

Moderna 'confident' jab will protect against Omicron

The chief medical officer of Moderna has said he is "confident" that the company's Covid jab will offer a "good level of protection" against the Omicron variant. Paul Burton said: "If there was ever a time to get a vaccine, I think now is it; and if you've been vaccinated, now is the time to get boosted … the best gift you can give to yourself or a loved one this holiday season is to get vaccinated." Report by Buseld. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:27Published
Health Secretary announces purchase of extra vaccine doses [Video]

Health Secretary announces purchase of extra vaccine doses

Health Secretary Sajid Javid announces the government have purchased an additional 114 million doses from Pfizer and Moderna. He says these will be for 2022 and 2023, and will be the companies' "latest" vaccines at that time. Report by Edwardst. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:28Published

Related videos from verified sources

How Jerry Meade Got COVID [Video]

How Jerry Meade Got COVID

This video offers some basic facts concerning how our dear friend Gerard T. ("Jerry") Meade was infected with COVID the evening of Sunday, November 21, 2021. Sadly, Jerry died on..

Credit: Rumble     Duration: 30:04Published
Covid-19 update: India registers over 2.82 lakh cases, 441 deaths | Oneindia News [Video]

Covid-19 update: India registers over 2.82 lakh cases, 441 deaths | Oneindia News

As Omicron variant of coronavirus drives new Covid-19 cases in India, the country registered 2,82,970 new infections in a day even as many cities have been reporting a decline. #Covid19..

Credit: Oneindia     Duration: 01:48Published
Biden addresses nation on the omicron variant amid COVID-19 surge | USA TODAY [Video]

Biden addresses nation on the omicron variant amid COVID-19 surge | USA TODAY

More than 1 million cases were reported in the U.S. on Monday. However, many of the cases were likely backlogged from the New President Biden receives COVID-19 booster shotv=REB8K.. President Joe Biden..

Credit: Rumble     Duration: 12:12Published

Related news from verified sources

Omicron may force drug companies to tweak Covid vaccination plans

The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and...
IndiaTimes